Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: The Japan Public Health Center-based Prospective Study Cohort II

Preventive Medicine

Volumn 55, Issue 2, 2012, Pages 137-143

  Michikawa, Takehiro ^a,b   Inoue, Manami ^b   Sawada, Norie ^b   Iwasaki, Motoki ^b   Tanaka, Yasuhito ^c   Shimazu, Taichi ^b   Sasazuki, Shizuka ^b   Yamaji, Taiki ^b   Mizokami, Masashi ^d   Tsugane, Shoichiro ^b   Inoue, M ^b   Sobue, T ^b   Hanaoka, T ^b   Ogata, J ^e   Baba, S ^e   Mannami, T ^e   Okayama, A ^e   Kokubo, Y ^e   Miyakawa, K ^f   Saito, F ^f   Koizumi, A ^f   Sano, Y ^f   Hashimoto, I ^f   Ikuta, T ^f   Tanaba, Y ^f   Miyajima, Y ^g   Suzuki, N ^g   Nagasawa, S ^g   Furusugi, Y ^g   Nagai, N ^g   Ito, Y ^g   Sanada, H ^h   Hatayama, Y ^h   Kobayashi, F ^h   Uchino, H ^h   Shirai, Y ^h   Kondo, T ^h   Sasaki, R ^h   Watanabe, Y ^h   Miyagawa, Y ^h   Kobayashi, Y ^h   Machida, M ^h   Kishimoto, Y ⁱ   Takara, E ⁱ   Fukuyama, T ⁱ   Kinjo, M ⁱ   Irei, M ⁱ   Sakiyama, H ^i,o   Imoto, K ^j   Yazawa, H ^j   Seo, T ^j   Seiko, A ^j   Ito, F ^j   Shoji, F ^j   Saito, R ^j   Murata, A ^k   Minato, K ^k   Motegi, K ^k   Fujieda, T ^k   Yamato, S ^k   Matsui, K ^l   Abe, T ^l   Katagiri, M ^l   Suzuki, M ^l   Doi, M ^m   Terao, A ^m   Ishikawa, Y ^m   Tagami, T ^m   Sueta, H ⁿ   Doi, H ⁿ   Urata, M ⁿ   Okamoto, N ⁿ   Ide, F ⁿ   Goto, H ⁿ   Onga, N ^o   Takaesu, H ^o   Uehara, M ^o   Horii, F ^p   Asano, I ^p   Yamaguchi, H ^p   Aoki, K ^p   Maruyama, S ^p   Ichii, M ^p   Takano, M ^p   Tsubono, Y ^q   Suzuki, K ^r   Honda, Y ^s   Yamagishi, K ^s   Sakurai, S ^s   Tsuchiya, N ^s   Kabuto, M ^a   Yamaguchi, M ^t   Matsumura, Y ^t   Sasaki, S ^t   Watanabe, S ^t   Akabane, M ^u   Kadowaki, T ^v   Noda, M ^w   Mizoue, T ^w   Kawaguchi, Y ^x   Takashima, Y ^y   Yoshida, Y ^y   Nakamura, K ^z   Matsushima, S ^aa   Natsukawa, S ^aa   Shimizu, H ^ab   Sugimura, H ^ac   Tominaga, S ^ad   Hamajima, N ^ae   Iso, H ^af   Iida, M ^ag   Ajiki, W ^ag   Ioka, A ^ag   Sato, S ^ah   Maruyama, E ^ai   Konishi, M ^aj   Okada, K ^aj   Saito, I ^aj   Yasuda, N ^ak   Kono, S ^al   Akiba, S ^am   more..

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d 1 7 1 Kohnodai   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f Iwate Prefectural Ninohe Public Health Center   (Japan)

^g Akita Prefectural Yokote Public Health Center   (Japan)

^h Nagano Prefectural Saku Public Health Center   (Japan)

ⁱ Okinawa Prefectural Chubu Public Health Center   (Japan)

^j Katsushika Public Health Center   (Japan)

^k Ibaraki Prefectural Mito Public Health Center   (Japan)

^l Niigata Prefectural Kashiwazaki and Nagaoka Public Health Center   (Japan)

^m Kochi Prefectural Chuo higashi Public Health Center   (Japan)

ⁿ Nagasaki Prefectural Kamigoto Public Health Center   (Japan)

^o Okinawa Prefectural Miyako Public Health Center   (Japan)

^p Osaka Prefectural Suita Public Health Center   (Japan)

^q TOHOKU UNIVERSITY   (Japan)

^r RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^s UNIVERSITY OF TSUKUBA   (Japan)

^t NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^u TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^v UNIVERSITY OF TOKYO   (Japan)

^w NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^x TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^y KYORIN UNIVERSITY   (Japan)

^z NIIGATA UNIVERSITY   (Japan)

^aa Saku General Hospital   (Japan)

^ab Sakihae Institute   (Japan)

^ac HAMAMATSU UNIVERSITY   (Japan)

^ad AICHI CANCER CENTER HOSPITAL   (Japan)

^ae NAGOYA UNIVERSITY   (Japan)

^af OSAKA UNIVERSITY   (Japan)

^ag OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^ah CHIBA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^ai KOBE UNIVERSITY   (Japan)

^aj EHIME UNIVERSITY   (Japan)

^ak KOCHI UNIVERSITY   (Japan)

^al KYUSHU UNIVERSITY   (Japan)

^am KAGOSHIMA UNIVERSITY   (Japan)

more..

Author keywords

Hepatitis virus; Hepatocellular carcinoma; Lifestyle; Population based; Prediction

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; COFFEE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; JAPANESE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE;

EID: 84863774717     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2012.05.017     Document Type: Article

References (39)

1. Abdel-Hamid M., El-Daly M., El-Kafrawy S., Mikhail N., Strickland G.T., Fix A.D. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J. Clin. Microbiol. 2002, 40:1656-1659.
2. Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Bouvard V., Altieri A., Cogliano V. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007, 8:292-293.
3. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180-187.
4. Davila J.A., Morgan R.O., Shaib Y., McGlynn K.A., El-Serag H.B. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005, 54:533-539.
5. Donato F., Boffetta P., Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int. J. Cancer 1998, 75:347-354.
6. Evans A.A., Chen G., Ross E.A., Shen F.M., Lin W.Y., London W.T. Eight-year follow-up of the 90,000-person Haimen City cohort: I. hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol. Biomarkers Prev. 2002, 11:369-376.
7. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] 2010, International Agency for Research on Cancer, Lyon, France, Available from: http://globocan.iarc.fr, accessed on January 10, 2012.
8. Fujita Y., Shibata A., Ogimoto I., Kurozawa Y., Nose T., Yoshimura T., Suzuki H., Iwai N., Sakata R., et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br. J. Cancer 2006, 94:737-739.
9. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 1996, 15:361-387.
10. Hassan M.M., Hwang L.Y., Hatten C.J., Swaim M., Li D., Abbruzzese J.L., Beasley P., Patt Y.Z. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206-1213.
11. Iida M., Sato S., Nakamura M. Standardization of laboratory test in the JPHC study. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J. Epidemiol. 2001, 11(Suppl.):S81-S86.
12. Inoue M., Tsugane S. Impact of alcohol drinking on total cancer risk: data from a large-scale population-based cohort study in Japan. Br. J. Cancer 2005, 92:182-187.
13. Inoue M., Iwasaki M., Otani T., Sasazuki S., Noda M., Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch. Intern. Med. 2006, 166:1871-1877.
14. Inoue M., Kurahashi N., Iwasaki M., Tanaka Y., Mizokami M., Noda M., Tsugane S. Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II). Cancer Causes Control 2009, 20:741-750.
15. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans, volume 82, some traditional herbal medicines, some mycotoxins, naphthalene and styrene 2004, World Health Organization, Lyon, France.
16. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans, volume 83, tobacco smoke and involuntary smoking 2004, World Health Organization, Lyon, France.
17. Ishiguro S., Inoue M., Tanaka Y., Mizokami M., Iwasaki M., Tsugane S. Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: a population-based cohort study (JPHC Study). Cancer Lett. 2010, 300:173-179.
18. Loughin T.M., Kochler K.J. Bootstrapping regression parameters in multivariate survival analysis. Lifetime Data Anal. 1997, 3:157-177.
19. Mackay J., Eriksen M. The tabacco atlas 2002, World Health Organization, Geneve, Switzerland.
20. Mori M., Hara M., Wada I., Hara T., Yamamoto K., Honda M., Naramoto J. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am. J. Epidemiol. 2000, 151:131-139.
21. Ohishi W., Fujiwara S., Cologne J.B., Suzuki G., Akahoshi M., Nishi N., Takahashi I., Chayama K. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol. Biomarkers Prev. 2008, 17:846-854.
22. Ohki T., Tateishi R., Sato T., Masuzaki R., Imamura J., Goto T., Yamashiki N., Yoshida H., Kanai F., et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin. Gastroenterol. Hepatol. 2008, 6:459-464.
23. Park Y., Freedman A.N., Gail M.H., Pee D., Hollenbeck A., Schatzkin A., Pfeiffer R.M. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J. Clin. Oncol. 2009, 27:694-698.
24. Shi J., Zhu L., Liu S., Xie W.F. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br. J. Cancer 2005, 92:607-612.
25. Steyerberg E. Clinical prediction models: a practical approach to development, validation, and updating 2009, Springer, New York, USA.
26. Sugita-Konishi Y., Sato T., Saito S., Nakajima M., Tabata S., Tanaka T., Norizuki H., Itoh Y., Kai S., et al. Exposure to aflatoxins in Japan: risk assessment for aflatoxin B1. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2010, 27:365-372.
27. Sullivan L.M., Massaro J.M., D'Agostino R.B. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat. Med. 2004, 23:1631-1660.
28. Tanaka K., Sakai H., Hashizume M., Hirohata T. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn. J. Cancer Res. 1998, 89:1241-1250.
29. Tanaka K., Tsuji I., Wakai K., Nagata C., Mizoue T., Inoue M., Tsugane S. Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. Jpn. J. Clin. Oncol. 2006, 36:445-456.
30. Tanaka H., Imai Y., Hiramatsu N., Ito Y., Imanaka K., Oshita M., Hijioka T., Katayama K., Yabuuchi I., et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann. Intern. Med. 2008, 148:820-826.
31. Tanaka K., Tsuji I., Wakai K., Nagata C., Mizoue T., Inoue M., Tsugane S. Alcohol drinking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn. J. Clin. Oncol. 2008, 38:816-838.
32. Tsugane S., Sobue T. Baseline survey of JPHC study-design and participation rate. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J. Epidemiol. 2001, 11(Suppl.):S24-S29.
33. Tsukuma H., Tanaka H., Ajiki W., Oshima A. Liver cancer and its prevention. Asian Pac. J. Cancer Prev. 2005, 6:244-250.
34. Umemura T., Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol. Res. 2007, 37(Suppl. 2):S95-S100.
35. Wen C.P., Tsai S.P., Chen C.J., Cheng T.Y. The mortality risks of smokers in Taiwan: part I: cause-specific mortality. Prev. Med. 2004, 39:528-535.
36. World Cancer Research Fund/American Institute for Cancer Research Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007, American Institute for Cancer Research, Washington DC, USA.
37. World Health Organization International classification of diseases for oncology 2000, World Health Organization, Geneve, Switzerland. 3rd edn.
38. Yu M.C., Yuan J.M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004, 127(5 Suppl 1):S72-S78.
39. Yuan J.M., Govindarajan S., Arakawa K., Yu M.C. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004, 101:1009-1017.